Global Anti-Neoplastic Agents Market Estimated To Grow And Attain Over USD 27.12 Billion by 2032

As per Zion Market Research, the global Anti-Neoplastic Agents Market was worth USD 11.10 Billion in 2023. The market is forecast to reach USD 27.12 Billion by 2032, growing at a compound annual growth rate (CAGR) of 10.56% during the forecast period 2024-2032. The second main cause of death across the U.S. is cancer after cardiovascular diseases and is predicted to rise to become the leading cause of casualty in the upcoming few years. As per CDC (Center for Disease Control and Prevention), the malignant neoplasms accounted for over 10.56% of deaths globally in 2012 and more than 19.2 million new cases of cancer are likely to be diagnosed by the end of 2032. The surging number is the main challenge to researchers and physicians to fulfill the unfulfilled needs in the treatment of malignant neoplasms. The anti-neoplastic agents are utilized significantly as a first-line therapy for treating cancer along with radiation therapy or surgery.

Some of the prominent players in the global market are Teva pharmaceutical Industries Ltd.; Amgen Inc.; Hoffmann-La Roche Ltd.; Bristol-Myers Squibb Company; Aspen Global Inc.; Boehringer Ingelheim GmbH; Bayer AG; Merc & Co., Inc.; Johnson & Johnson Pvt. Ltd.; Baxter Healthcare Corporation; Accord Healthcare, Inc.; Pfizer Inc.; Lundbeck LLC; Genentech, Inc.; and AbbVie Inc.

Increasing Research And Development Activities To Boost The Global Anti-Neoplastic Agents Market

The rising investment by multinational firms in cancer research due to augmenting the prevalence of cancer is likely to boost the global market during the forecasted period. On the account of product type, the anti-neoplastic agents are categorized into chemotherapeutic agents, personalized medicine, and biological or immunotherapeutic agents. The chemotherapeutic agents section is expected to dominate the market due to easy accessibility of drugs and the immunotherapeutic agents section is likely to grow rapidly due to rising acceptance of biological therapy as a result of lesser side effects.

The global anti-neoplastic agents market is bifurcated on the basis of product type, end-users/application, and regional analysis. Based on the product type, the market is divided into targeted therapy, chemotherapy, hormonal therapy (biologic therapy), immunotherapy, and others. Based on the end-users/application, the market is divided into breast cancer, blood cancer, prostate cancer, gastrointestinal cancer, respiratory/lung cancer, and other cancers.

The North America Region Expected To Dominate The Global Anti-Neoplastic Agents Market

Based on geographical analysis, the global anti-neoplastic agents market is divided into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. The North American region is projected to continue ruling the global anti-neoplastic agents market owing to the higher prevalence of malignant neoplasm. Europe is anticipated to hold the second-largest market share in the global market. According to Cancer Research UK, in 2013, above 605 people from general population of 100,000 were identified with cancer.

Browse the full “Anti-Neoplastic Agents Market - By Product Type (Targeted Therapy, Chemotherapy, Hormonal Therapy (Biologic Therapy), Immunotherapy, and Others), By End-Users/Application (Breast Cancer, Blood Cancer, Prostate Cancer, Gastrointestinal Cancer, Respiratory/Lung Cancer, and Other Cancers), And By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024 – 2032.” Report at https://www.zionmarketresearch.com/report/anti-neoplastic-agents-market

The global anti-neoplastic agents market is segmented as follows:

By product type:

• Chemotherapy
• Targeted Therapy
• Immunotherapy
• Hormonal Therapy (Biologic Therapy)
• Others

By end-users/application:

• Blood cancer
• Breast cancer
• Gastrointestinal cancer
• Prostate cancer
• Respiratory/lung cancer
• Other cancers

By region:

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com